Validation of plastic scintillation detectors for applications in low-dose-rate brachytherapy

Monte Carlo dosimetric characterization of a new high dose rate 169 Yb brachytherapy source and independent verification using a multipoint plastic scintillator detector

PURPOSE

A prototype 169 Yb source was developed in combination with a dynamic rotating platinum shield system (AIM-Brachy) to deliver intensity modulated brachytherapy (IMBT). The purpose of this study was to evaluate the dosimetric characteristics of the bare/shielded 169 Yb source using Monte Carlo (MC) simulations and perform an independent dose verification using a dosimetry platform based on a multipoint plastic scintillator detector (mPSD).

METHODS

The TG-43U1 dosimetric parameters were calculated for the source model using RapidBrachyMCTPS. Real-time dose rate measurements were performed in a water tank for both the bare/shielded source using a custom remote afterloader. For each dwell position, the dose rate was independently measured by the three scintillators (BCF-10, BCF-12, and BCF-60). For the bare source, dose rate was measured at distances up to 3 cm away from the source over a range of 7 cm along the catheter. For the shielded source, measurements were performed with the mPSD placed at 1 cm from the source at four different azimuthal angles ( 0 ∘ , 9 0 ∘ , 18 0 ∘ , and 27 0 ∘ ).

RESULTS

The dosimetric parameters were tabulated for the source model. For the bare source, differences between measured and calculated along-away dose rates were generally below 5-10%. Along the transverse axis, deviations were, on average (range), 3.3% (0.6-6.2%) for BCF-10, 1.7% (0.9-2.9%) for BCF-12, and 2.2% (0.3-4.4%) for BCF-60. The maximum dose rate reduction due to shielding at a radial distance of 1 cm was 88.8 ± 1.2%, compared to 83.5 ± 0.5% as calculated by MC.

CONCLUSIONS

The dose distribution for the bare/shielded 169 Yb source was independently verified using mPSD with good agreement in regions close to the source. The 169 Yb source coupled with the partial-shielding system is an effective technique to deliver IMBT.

Optimization of a multipoint plastic scintillator dosimeter for high dose rate brachytherapy

PURPOSE

This study is devoted to optimizing and characterizing the response of a multipoint plastic scintillator detector (mPSD) for application to in vivo dosimetry in high dose rate (HDR) brachytherapy.

METHODS

An exhaustive analysis was carried out in order to obtain an optimized mPSD design that maximizes the scintillation light collection produced by the interaction of ionizing photons. More than 20 prototypes of mPSD were built and tested in order to determine the appropriate order of scintillators relative to the photodetector (distal, center, or proximal) as well as their length as a function of the scintillation light emitted. The available detecting elements are the BCF-60, BCF-12, and BCF-10 scintillators (Saint Gobain Crystals, Hiram, OH, USA), separated from each other by segments of Eska GH-4001 clear optical fibers (Mitsubishi Rayon Co., Ltd., Tokyo, Japan). The contribution of each scintillator to the total spectrum was determined by irradiations in the low energy range (<120 keV). For the best mPSD design, a numerical optimization was done in order to select the optical components [dichroic mirrors, filters, and photomultipliers tubes (PMTs)] that best match the light emission profile. Calculations were performed taking into account the measured scintillation spectrum and light yield, the manufacturer-reported transmission and attenuation of the optical components, and the experimentally characterized PMT noise. The optimized dosimetric system was used for HDR brachytherapy measurements. The system was independently controlled from the 192 Ir source via LabVIEW and read simultaneously using an NI-DAQ board. Dose measurements as a function of distance from the source were carried out according to TG-43U1 recommendations. The system performance was quantified in terms of signal to noise ratio (SNR) and signal to background ratio (SBR).

RESULTS

For best overall light-yield emission, it was determined that BCF-60 should be placed at the distal position, BCF-12 in the center, and BCF-10 at the proximal position with respect to the photodetector. This configuration allowed for optimized light transmission through the collecting fiber and avoided inter-scintillator excitation and self-absorption effects. The optimal scintillator length found was of 3, 6, and 7 mm for BCF-10, BCF- 12, and BCF-60, respectively. The optimized luminescence system allowed for signal deconvolution using a multispectral approach, extracting the dose to each element while taking into account the Cerenkov stem effect. Differences between the mPSD measurements and TG-43U1 remain below 5% in the range of 0.5 to 6.5 cm from the source. The dosimetric system can properly differentiate the scintillation signal from the background for a wide range of dose rate conditions; the SNR was found to be above 5 for dose rates above 22 mGy/s while the minimum SBR measured was 1.8 at 6 mGy/s.

CONCLUSION

Based on the spectral response at different conditions, an mPSD was constructed and optimized for HDR brachytherapy dosimetry. It is sensitive enough to allow multiple simultaneous measurements over a clinically useful distance range, up to 6.5 cm from the source. This study constitutes a baseline for future applications enabling real-time dose measurements and source position reporting over a wide range of dose rate conditions.